MCDONOUGH JOHN (President & CEO) sold 4.6% of their position (23.75K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market sale worth $20.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/5/2020ACC: 0000899243-20-003299
DirectorOfficer· President & CEO
Since Jul 2018
-23.75K
Net shares
Net seller
$20.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
23.75K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−23.75K
Price / share
$0.88
Trade value
$20.90K
% of position
4.6%
2/3/2020
512.87K→489.11K
Total
Net shares
−23.75K
Net value
-$20.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2020 | S · Sale | −23.75K | $0.88 | $20.90K | 4.6% | 512.87K | 489.11K |
| Total | −23.75K | -$20.90K | ||||||
Derivative Transactions0
No derivative transactions reported